Becton Dickinson and Stock Price, News & Analysis (NYSE:BDX)

$222.87 +0.36 (+0.16 %)
(As of 02/20/2018 02:36 AM ET)
Previous Close$222.51
Today's Range$221.28 - $224.85
52-Week Range$175.66 - $248.39
Volume981,500 shs
Average Volume1.64 million shs
Market Capitalization$51.13 billion
P/E Ratio170.13
Dividend Yield1.35%
Beta1.12

About Becton Dickinson and (NYSE:BDX)

Becton Dickinson and logoBecton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Supplies
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNYSE:BDX
CUSIP07588710
Phone+1-201-8476800

Debt

Debt-to-Equity Ratio1.04%
Current Ratio1.54%
Quick Ratio0.93%

Price-To-Earnings

Trailing P/E Ratio170.129770992366
Forward P/E Ratio20.37
P/E Growth1.59

Sales & Book Value

Annual Sales$12.09 billion
Price / Sales4.91
Cash Flow$14.11 per share
Price / Cash15.80
Book Value$56.89 per share
Price / Book3.92

Profitability

Trailing EPS$1.31
Net Income$1.10 billion
Net Margins2.71%
Return on Equity16.19%
Return on Assets5.74%

Miscellaneous

Employees41,933
Outstanding Shares266,240,000

Becton Dickinson and (NYSE:BDX) Frequently Asked Questions

What is Becton Dickinson and's stock symbol?

Becton Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton Dickinson and pay dividends? What is the dividend yield for Becton Dickinson and?

Becton Dickinson and announced a quarterly dividend on Monday, January 22nd. Investors of record on Friday, March 9th will be given a dividend of $0.75 per share on Friday, March 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend is Thursday, March 8th. View Becton Dickinson and's Dividend History.

How were Becton Dickinson and's earnings last quarter?

Becton Dickinson and Co (NYSE:BDX) announced its earnings results on Tuesday, February, 6th. The medical instruments supplier reported $2.48 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.41 by $0.07. The medical instruments supplier earned $3.08 billion during the quarter, compared to analyst estimates of $3.05 billion. Becton Dickinson and had a return on equity of 16.19% and a net margin of 2.71%. The business's revenue for the quarter was up 5.4% on a year-over-year basis. During the same period in the prior year, the company earned $2.33 EPS. View Becton Dickinson and's Earnings History.

When will Becton Dickinson and make its next earnings announcement?

Becton Dickinson and is scheduled to release their next quarterly earnings announcement on Monday, April, 30th 2018. View Earnings Estimates for Becton Dickinson and.

What guidance has Becton Dickinson and issued on next quarter's earnings?

Becton Dickinson and updated its FY18 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of $10.85-11.00 for the period, compared to the Thomson Reuters consensus estimate of $10.88.

Where is Becton Dickinson and's stock going? Where will Becton Dickinson and's stock price be in 2018?

15 analysts have issued 1-year price objectives for Becton Dickinson and's stock. Their predictions range from $180.00 to $260.00. On average, they expect Becton Dickinson and's share price to reach $235.71 in the next year. View Analyst Ratings for Becton Dickinson and.

Are investors shorting Becton Dickinson and?

Becton Dickinson and saw a drop in short interest during the month of January. As of January 12th, there was short interest totalling 4,178,127 shares, a drop of 64.1% from the December 29th total of 11,647,459 shares. Based on an average daily trading volume, of 1,668,895 shares, the short-interest ratio is currently 2.5 days. Approximately 1.8% of the company's stock are sold short.

Who are some of Becton Dickinson and's key competitors?

Who are Becton Dickinson and's key executives?

Becton Dickinson and's management team includes the folowing people:

  • Vincent A. Forlenza, Chairman of the Board, Chief Executive Officer (Age 64)
  • Thomas E. Polen, President (Age 44)
  • Christopher R. Reidy, Chief Financial Officer, Executive Vice President, Chief Administrative Officer (Age 60)
  • Linda M. Tharby, Chief Human Resource Officer, Executive Vice President (Age 49)
  • Nabil Shabshab, Executive Vice President - Strategic Planning Chief Marketing Officer (Age 52)
  • Alexandre Conroy, Executive Vice President and President, Europe, EMA (Age 54)
  • James Lim, Executive Vice President and President, Greater Asia (Age 53)
  • Alberto Mas, Executive Vice President and President - Life Sciences Segment (Age 56)
  • Catherine M. Burzik, Independent Director (Age 67)
  • R. Andrew Eckert, Independent Director (Age 56)

Who owns Becton Dickinson and stock?

Becton Dickinson and's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.07%), Franklin Resources Inc. (1.39%), Geode Capital Management LLC (0.83%), Jensen Investment Management Inc. (0.82%), Renaissance Technologies LLC (0.78%) and Bank of New York Mellon Corp (0.76%). Company insiders that own Becton Dickinson and stock include Ellen R Strahlman, Gary M Cohen, James C Lim, James F Orr, Jeffrey S Sherman, Jerome V Hurwitz, John E Gallagher, Linda M Tharby, Nabil Shabshab, Rebecca W Rimel, Ribo Alberto Mas, Stephen Sichak, Thomas E Polen Jr, Timothy M Ring and Vincent A Forlenza. View Institutional Ownership Trends for Becton Dickinson and.

Who sold Becton Dickinson and stock? Who is selling Becton Dickinson and stock?

Becton Dickinson and's stock was sold by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Winslow Capital Management LLC, Los Angeles Capital Management & Equity Research Inc., Sei Investments Co., Jensen Investment Management Inc., Cooke & Bieler LP, British Airways Pensions Investment Management Ltd and Mawer Investment Management Ltd.. Company insiders that have sold Becton Dickinson and company stock in the last year include Ellen R Strahlman, Gary M Cohen, Jeffrey S Sherman, Linda M Tharby, Nabil Shabshab, Ribo Alberto Mas, Stephen Sichak, Thomas E Polen Jr and Timothy M Ring. View Insider Buying and Selling for Becton Dickinson and.

Who bought Becton Dickinson and stock? Who is buying Becton Dickinson and stock?

Becton Dickinson and's stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, BlackRock Inc., Amundi Pioneer Asset Management Inc., Gardner Lewis Asset Management L P, HBK Investments L P, TIAA CREF Investment Management LLC, Alpine Associates Management Inc. and Mackenzie Financial Corp. View Insider Buying and Selling for Becton Dickinson and.

How do I buy Becton Dickinson and stock?

Shares of Becton Dickinson and can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Becton Dickinson and's stock price today?

One share of Becton Dickinson and stock can currently be purchased for approximately $222.87.

How big of a company is Becton Dickinson and?

Becton Dickinson and has a market capitalization of $51.13 billion and generates $12.09 billion in revenue each year. The medical instruments supplier earns $1.10 billion in net income (profit) each year or $1.31 on an earnings per share basis. Becton Dickinson and employs 41,933 workers across the globe.

How can I contact Becton Dickinson and?

Becton Dickinson and's mailing address is 1 Becton Dr, FRANKLIN LAKES, NJ 07417-1815, United States. The medical instruments supplier can be reached via phone at +1-201-8476800.


MarketBeat Community Rating for Becton Dickinson and (BDX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  329 (Vote Outperform)
Underperform Votes:  430 (Vote Underperform)
Total Votes:  759
MarketBeat's community ratings are surveys of what our community members think about Becton Dickinson and and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Becton Dickinson and (NYSE:BDX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.802.752.62
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
7 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
7 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $235.71$232.00$215.67$193.42
Price Target Upside: 4.68% upside0.05% downside3.90% downside3.47% downside

Becton Dickinson and (NYSE:BDX) Consensus Price Target History

Price Target History for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and (NYSE:BDX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/7/2018Morgan StanleyBoost Price TargetEqual Weight -> Equal Weight$245.00 -> $250.00LowView Rating Details
2/6/2018Piper Jaffray CompaniesReiterated RatingOverweight$223.00 -> $260.00LowView Rating Details
1/19/2018Bank of AmericaReiterated RatingBuy -> Buy$260.00MediumView Rating Details
1/5/2018CitigroupUpgradeSell -> NeutralLowView Rating Details
1/5/2018KeyCorpInitiated CoverageOverweight -> Overweight$260.00LowView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform -> Outperform$245.00MediumView Rating Details
12/29/2017Deutsche BankSet Price TargetBuy -> Buy$239.00 -> $260.00LowView Rating Details
12/14/2017ArgusBoost Price TargetAverage -> Buy$235.00LowView Rating Details
11/3/2017Stifel NicolausReiterated RatingBuy$245.00N/AView Rating Details
11/3/2017Royal Bank of CanadaReiterated RatingSector Perform -> Sector Perform$210.00 -> $230.00N/AView Rating Details
10/24/2017Wells Fargo & CoReiterated RatingOutperform -> Positive$225.00 -> $235.00N/AView Rating Details
8/14/2017CowenReiterated RatingBuy$230.00LowView Rating Details
8/10/2017BarclaysReiterated RatingEqual Weight$205.00 -> $210.00LowView Rating Details
6/30/2017Raymond James FinancialUpgradeOutperform -> Strong-Buy$210.00 -> $180.00LowView Rating Details
3/29/2017Jefferies GroupReiterated RatingBuy$200.00LowView Rating Details
1/3/2017JPMorgan Chase & Co.DowngradeOverweight -> Neutral$190.00 -> $175.00N/AView Rating Details
11/21/2016Leerink SwannReiterated RatingMarket Perform$180.00 -> $185.00N/AView Rating Details
4/8/2016Goldman Sachs GroupBoost Price Target$156.00 -> $157.00N/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Becton Dickinson and (NYSE:BDX) Earnings History and Estimates Chart

Earnings by Quarter for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and (NYSE BDX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018$2.62N/AView Earnings Details
2/6/2018Q1 2018$2.41$2.48$3.05 billion$3.08 billionViewListenView Earnings Details
11/2/2017Q4 2017$2.37$2.40$3.14 billion$3.17 billionViewN/AView Earnings Details
8/3/2017Q3 2017$2.44$2.46$3.06 billion$3.04 billionViewListenView Earnings Details
5/2/2017Q2 2017$2.23$2.30$2.92 billion$2.97 billionViewListenView Earnings Details
2/2/2017Q117$2.11$2.33$2.86 billion$2.92 billionViewListenView Earnings Details
11/3/2016Q416$2.09$2.12$3.22 billion$3.23 billionViewListenView Earnings Details
8/4/2016Q316$2.20$2.35$3.21 billion$3.20 billionViewListenView Earnings Details
5/5/2016Q216$2.02$2.18$3.07 billion$3.07 billionViewListenView Earnings Details
2/3/2016Q116$1.84$1.96$3.04 billion$2.99 billionViewListenView Earnings Details
11/4/2015Q415$1.90$1.94$3.04 billion$3.07 billionViewListenView Earnings Details
8/6/2015Q315$2.01$2.05$3.13 billion$3.12 billionViewListenView Earnings Details
5/7/2015Q2$1.54$1.61$2.05 billion$2.05 billionViewListenView Earnings Details
2/5/2015Q115$1.43$1.53$2.04 billion$2.05 billionViewListenView Earnings Details
11/4/2014Q414$1.65$1.68$2.16 billion$2.20 billionViewListenView Earnings Details
7/31/2014Q314$1.68$1.68$2.14 billion$2.16 billionViewListenView Earnings Details
5/1/2014Q2$1.50$1.53$2.09 billion$2.07 billionViewListenView Earnings Details
2/4/2014Q114$1.30$1.42$1.98 billion$2.00 billionViewListenView Earnings Details
11/5/2013Q413$1.46$1.52$2.05 billion$2.10 billionViewListenView Earnings Details
8/1/2013Q3 2013$1.48$1.58$2.05 million$2.05 billionViewListenView Earnings Details
5/2/2013Q2 2013$1.35$1.44$1.99 billion$2.00 billionViewListenView Earnings Details
2/5/2013Q1 2013$1.24$1.35$1.86 billion$1.90 billionViewListenView Earnings Details
11/7/2012Q412$1.40$1.42$1.96 billion$1.97 billionViewN/AView Earnings Details
8/2/2012$1.53$1.52ViewN/AView Earnings Details
5/1/2012$1.38$1.38ViewN/AView Earnings Details
2/7/2012$1.17$1.21ViewN/AView Earnings Details
11/2/2011$1.41$1.39ViewN/AView Earnings Details
8/2/2011$1.43$1.53ViewN/AView Earnings Details
4/26/2011$1.30$1.38ViewN/AView Earnings Details
2/7/2011$1.29$1.35ViewN/AView Earnings Details
11/3/2010Q4 2010$1.25$1.24ViewN/AView Earnings Details
7/29/2010Q3 2010$1.25$1.29ViewN/AView Earnings Details
4/29/2010Q2 2010$1.23$1.24ViewN/AView Earnings Details
1/28/2010Q1 2010$1.20$1.30ViewN/AView Earnings Details
11/4/2009Q4 2009$1.24$1.25ViewN/AView Earnings Details
7/30/2009Q3 2009$1.24$1.30ViewN/AView Earnings Details
4/28/2009Q2 2009$1.16$1.18ViewN/AView Earnings Details
1/27/2009Q1 2009$1.16$1.26ViewN/AView Earnings Details
11/5/2008Q4 2008$1.12$1.13ViewN/AView Earnings Details
7/24/2008Q3 2008$1.10$1.18ViewN/AView Earnings Details
4/23/2008Q2 2008$1.04$1.09ViewN/AView Earnings Details
1/24/2008Q1 2008$1.03$1.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Becton Dickinson and (NYSE:BDX) Earnings Estimates

2018 EPS Consensus Estimate: $10.75
2019 EPS Consensus Estimate: $12.69
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$2.28$2.28$2.28
Q2 20183$2.56$2.65$2.61
Q3 20183$2.80$2.98$2.86
Q4 20182$2.95$3.04$3.00
Q1 20191$3.05$3.05$3.05
Q2 20191$3.09$3.09$3.09
Q3 20191$3.22$3.22$3.22
Q4 20191$3.33$3.33$3.33
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Becton Dickinson and (NYSE:BDX) Dividend Information

Next Dividend:3/30/2018
Annual Dividend:$3.00
Dividend Yield:1.35%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:229.01% (Trailing 12 Months of Earnings)
27.42% (Based on This Year's Estimates)
23.75% (Based on Next Year's Estimates)
Track Record:46 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and (NYSE:BDX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/22/2018quarterly$0.750.00316843394871362%3/8/20183/9/20183/30/2018
11/20/2017quarterly$0.751.32%12/7/201712/8/201712/29/2017
7/25/2017quarterly$0.731.44%9/7/20179/8/20179/29/2017
5/23/2017quarterly$0.731.56%6/7/20176/9/20176/30/2017
1/23/2017quarterly$0.731.71%3/8/20173/10/20173/31/2017
11/21/2016quarterly$0.731.74%12/7/201612/9/201612/30/2016
7/26/2016quarterly$0.661.51%9/7/20169/9/20169/30/2016
5/24/2016quarterly$0.661.58%6/7/20166/9/20166/30/2016
1/25/2016quarterly$0.661.81%3/8/20163/10/20163/31/2016
11/23/2015quarterly$0.661.75%12/8/201512/10/201512/31/2015
7/28/2015quarterly$0.601.58%9/4/20159/9/20159/30/2015
5/19/2015quarterly$0.601.69%6/5/20156/9/20156/30/2015
1/27/2015quarterly$0.601.65%3/6/20153/10/20153/31/2015
11/25/2014quarterly$0.601.7%12/8/201412/10/201412/31/2014
7/22/2014quarterly$0.551.84%9/5/20149/9/20149/30/2014
5/20/2014quarterly$0.551.88%6/5/20146/9/20146/30/2014
1/28/2014quarterly$0.552.02%3/6/20143/10/20143/31/2014
11/26/2013quarterly$0.552%12/6/201312/10/201312/31/2013
7/23/2013quarterly$0.501.91%9/5/20139/9/20139/30/2013
5/21/2013quarterly$0.501.98%6/5/20136/7/20136/28/2013
1/29/2013quarterly$0.502.35%3/6/20133/8/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

Becton Dickinson and (NYSE BDX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.00%
Institutional Ownership Percentage: 77.50%
Insider Trades by Quarter for Becton Dickinson and (NYSE:BDX)
Insider Trades by Quarter for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and (NYSE BDX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/8/2018Timothy M RingDirectorSell269,661$217.82$58,737,559.02295,753View SEC Filing  
9/11/2017Gary M CohenInsiderSell15,512$203.77$3,160,880.2495,781View SEC Filing  
9/8/2017Stephen SichakInsiderSell11,787$200.46$2,362,822.0214,038View SEC Filing  
8/22/2017Gary M CohenInsiderSell15,044$200.43$3,015,268.9295,270View SEC Filing  
8/22/2017Linda M TharbyEVPSell4,695$200.48$941,253.6018,670View SEC Filing  
8/15/2017Nabil ShabshabInsiderSell6,149$201.76$1,240,622.2415,648View SEC Filing  
8/14/2017Ribo Alberto MasEVPSell7,463$201.41$1,503,122.8329,323View SEC Filing  
8/10/2017Ellen R StrahlmanInsiderSell9,283$198.21$1,839,983.4326,638View SEC Filing  
8/9/2017Thomas E Polen JrInsiderSell5,971$197.41$1,178,735.1112,861View SEC Filing  
5/25/2017Jeffrey S ShermanVPSell28,765$185.98$5,349,714.7070,821View SEC Filing  
2/15/2017Jeffrey S ShermanVPSell31,464$180.02$5,664,149.2822,094View SEC Filing  
12/15/2016John E GallagherVPSell1,793$168.82$302,694.262,796View SEC Filing  
12/5/2016Stephen SichakInsiderSell2,632$164.44$432,806.087,953View SEC Filing  
11/4/2016Stephen SichakInsiderSell10,352$176.10$1,822,987.2026,892View SEC Filing  
9/6/2016Linda M TharbyInsiderSell11,704$177.27$2,074,768.0822,146View SEC Filing  
8/11/2016Gary M CohenInsiderSell29,367$176.81$5,192,379.27125,870View SEC Filing  
6/13/2016John E GallagherVPSell1,931$169.87$328,018.976,758View SEC Filing  
6/7/2016Nabil ShabshabEVPSell5,080$168.75$857,250.0011,092View SEC Filing  
5/17/2016Jeffrey S ShermanVPSell34,373$166.27$5,715,198.7149,736View SEC Filing  
5/13/2016Stephen SichakEVPSell12,995$166.48$2,163,407.6031,561View SEC Filing  
5/13/2016Vincent A ForlenzaCEOSell37,933$166.17$6,303,326.61207,225View SEC Filing  
5/10/2016James F OrrDirectorSell1,368$167.66$229,358.8823,045View SEC Filing  
5/9/2016James C LimEVPSell5,257$165.60$870,559.2012,556View SEC Filing  
5/6/2016Ellen R StrahlmanSVPSell3,019$163.52$493,666.887,218View SEC Filing  
5/6/2016Jerome V HurwitzEVPSell3,878$163.58$634,363.243,027View SEC Filing  
5/6/2016Rebecca W RimelDirectorSell684$163.69$111,963.966,835View SEC Filing  
12/14/2015Stephen SichakEVPSell8,670$152.21$1,319,660.708,646View SEC Filing  
12/9/2015William A KozyEVPSell15,495$154.43$2,392,892.8568,823View SEC Filing  
12/8/2015Vincent A. ForlenzaCEOSell17,762$153.10$2,719,362.20172,681View SEC Filing  
12/7/2015Jeffrey S ShermanVPSell7,586$153.76$1,166,423.3623,734View SEC Filing  
12/1/2015Thomas E Polen JrEVPSell2,683$152.21$408,379.435,789View SEC Filing  
11/30/2015John E GallagherVPSell1,600$150.70$241,120.003,393View SEC Filing  
11/18/2015Jerome V. HurwitzEVPSell2,347$151.02$354,443.944,866View SEC Filing  
6/1/2015Stephen SichakEVPSell12,188$140.94$1,717,776.72View SEC Filing  
5/22/2015Thomas E Polen JrEVPSell3,882$142.56$553,417.92View SEC Filing  
5/21/2015Linda M TharbyEVPSell6,069$142.02$861,919.38View SEC Filing  
5/20/2015William A KozyEVPSell10,326$142.00$1,466,292.00View SEC Filing  
5/19/2015William A KozyEVPSell10,435$142.01$1,481,874.35View SEC Filing  
5/18/2015Bertram L ScottDirectorSell2,160$141.74$306,158.40View SEC Filing  
5/18/2015James C LimEVPSell3,604$141.80$511,047.20View SEC Filing  
5/15/2015Alexandre ConroyEVPSell1,291$141.37$182,508.67View SEC Filing  
5/13/2015Jeffrey S ShermanVPSell10,983$138.40$1,520,047.20View SEC Filing  
5/11/2015Jerome V HurwitzEVPSell1,197$141.43$169,291.71View SEC Filing  
5/8/2015Gary M CohenEVPSell13,490$142.90$1,927,721.00View SEC Filing  
6/12/2014Stephen SichakSVPSell1,456$118.25$172,172.00View SEC Filing  
6/10/2014Gary M CohenEVPSell12,476$119.24$1,487,638.24View SEC Filing  
6/9/2014Jeffrey S ShermanVPSell7,877$120.24$947,130.48View SEC Filing  
3/6/2014Jeffrey ShermanVPSell1,303$115.16$150,053.4827,768View SEC Filing  
11/12/2013William KozyEVPSell9,597$108.30$1,039,355.10101,090View SEC Filing  
11/11/2013Jeffrey ShermanVPSell4,272$107.78$460,436.1625,176View SEC Filing  
11/11/2013Jerome HurwitzSVPSell1,151$107.78$124,054.781,687View SEC Filing  
11/8/2013Vincent ForlenzaCEOSell32,411$107.39$3,480,617.29108,724View SEC Filing  
11/6/2013Henry Becton, Jr.DirectorSell2,276$106.77$243,008.5223,820View SEC Filing  
8/23/2013Bertram ScottDirectorSell4,047$98.61$399,074.6720,768View SEC Filing  
8/8/2013Edward DegraanDirectorSell4,436$100.03$443,733.0818,608View SEC Filing  
8/8/2013Stephen SichakSVPSell3,431$100.13$343,546.036,297View SEC Filing  
8/7/2013Basil AndersonDirectorSell2,160$99.79$215,546.4017,221View SEC Filing  
5/22/2013Henry P Becton JrDirectorSell3,117$101.86$317,497.62View SEC Filing  
5/17/2013Donna M BolesVPSell2,415$101.38$244,832.70View SEC Filing  
5/13/2013Gary M CohenEVPSell8,753$100.22$877,225.66View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Becton Dickinson and (NYSE BDX) News Headlines

Source:
DateHeadline
Morgan Stanley Raises Becton Dickinson and (BDX) Price Target to $250.00Morgan Stanley Raises Becton Dickinson and (BDX) Price Target to $250.00
www.americanbankingnews.com - February 19 at 10:48 PM
Major Drivers of Boston Scientific’s MedSurg Business Growth in 2018Major Drivers of Boston Scientific’s MedSurg Business Growth in 2018
finance.yahoo.com - February 19 at 8:20 AM
Medtronics Positive Study Results May Expand Customer Base - NasdaqMedtronic's Positive Study Results May Expand Customer Base - Nasdaq
www.nasdaq.com - February 17 at 8:16 AM
Zacks: Brokerages Expect Becton Dickinson and Co (BDX) to Announce $2.60 Earnings Per ShareZacks: Brokerages Expect Becton Dickinson and Co (BDX) to Announce $2.60 Earnings Per Share
www.americanbankingnews.com - February 17 at 3:04 AM
BRIEF-Becton Dickinson Files For Offering EUR 300 Mln Add. 0.368% NotesBRIEF-Becton Dickinson Files For Offering EUR 300 Mln Add. 0.368% Notes
www.reuters.com - February 16 at 8:20 AM
Chemed (CHE) Beats on Q4 Earnings & Revenues, Issues ViewChemed (CHE) Beats on Q4 Earnings & Revenues, Issues View
finance.yahoo.com - February 15 at 9:00 AM
BD Completes Asset Divestitures to Merit MedicalBD Completes Asset Divestitures to Merit Medical
finance.yahoo.com - February 15 at 9:00 AM
Bard’s Anticipated Product Launches in 2018Bard’s Anticipated Product Launches in 2018
finance.yahoo.com - February 14 at 9:51 AM
Amazon Could Enter Hospital Supply Chain — Why Medtech Shouldn't WorryAmazon Could Enter Hospital Supply Chain — Why Medtech Shouldn't Worry
finance.yahoo.com - February 13 at 3:46 PM
BRIEF-Becton Dickinson Says Received Pre-Market Approval From FDA For BD Onclarity HPV AssayBRIEF-Becton Dickinson Says Received Pre-Market Approval From FDA For BD Onclarity HPV Assay
www.reuters.com - February 13 at 9:58 AM
BDX’s New Reporting Structure after Bard AcquisitionBDX’s New Reporting Structure after Bard Acquisition
finance.yahoo.com - February 13 at 9:58 AM
What Wall Street Thinks about BD after 1Q18 Earnings ReleaseWhat Wall Street Thinks about BD after 1Q18 Earnings Release
finance.yahoo.com - February 13 at 9:58 AM
FDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical CancerFDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical Cancer
www.prnewswire.com - February 13 at 7:05 AM
Becton Dickinson and Co (BDX) Director Sells $58,737,559.02 in StockBecton Dickinson and Co (BDX) Director Sells $58,737,559.02 in Stock
www.americanbankingnews.com - February 12 at 3:16 PM
BD Medical Segment Posted Strong Fiscal 1Q18 PerformanceBD Medical Segment Posted Strong Fiscal 1Q18 Performance
finance.yahoo.com - February 12 at 9:50 AM
Analysts Offer Predictions for Becton Dickinson and Cos FY2018 Earnings (BDX)Analysts Offer Predictions for Becton Dickinson and Co's FY2018 Earnings (BDX)
www.americanbankingnews.com - February 9 at 1:43 PM
Jefferies Group Analysts Decrease Earnings Estimates for Becton Dickinson and Co (BDX)Jefferies Group Analysts Decrease Earnings Estimates for Becton Dickinson and Co (BDX)
www.americanbankingnews.com - February 9 at 10:54 AM
Q2 2018 Earnings Forecast for Becton Dickinson and Co Issued By Leerink Swann (BDX)Q2 2018 Earnings Forecast for Becton Dickinson and Co Issued By Leerink Swann (BDX)
www.americanbankingnews.com - February 9 at 10:54 AM
Q2 2018 Earnings Forecast for Becton Dickinson and Co Issued By KeyCorp (BDX)Q2 2018 Earnings Forecast for Becton Dickinson and Co Issued By KeyCorp (BDX)
www.americanbankingnews.com - February 9 at 10:54 AM
BD to Present at Leerink Partners 7th Annual Global Healthcare ConferenceBD to Present at Leerink Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 9 at 9:52 AM
Becton Dickinson and Co (BDX) Receives Average Rating of "Buy" from AnalystsBecton Dickinson and Co (BDX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - February 9 at 8:30 AM
Becton Dickinson and Co (BDX) to Post FY2018 Earnings of $10.95 Per Share, Jefferies Group ForecastsBecton Dickinson and Co (BDX) to Post FY2018 Earnings of $10.95 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - February 8 at 2:04 PM
Q3 2018 Earnings Estimate for Becton Dickinson and Co (BDX) Issued By Leerink SwannQ3 2018 Earnings Estimate for Becton Dickinson and Co (BDX) Issued By Leerink Swann
www.americanbankingnews.com - February 8 at 11:53 AM
Becton Dickinson (BDX) Q1 2018 Earnings Conference Call TranscriptBecton Dickinson (BDX) Q1 2018 Earnings Conference Call Transcript
finance.yahoo.com - February 8 at 8:13 AM
Becton, Dickinson Ready to Sing a New SongBecton, Dickinson Ready to Sing a New Song
finance.yahoo.com - February 8 at 8:13 AM
Piper Jaffray Companies Reaffirms "Overweight" Rating for Becton Dickinson and (BDX)Piper Jaffray Companies Reaffirms "Overweight" Rating for Becton Dickinson and (BDX)
www.americanbankingnews.com - February 6 at 4:34 PM
Becton Dickinson and (BDX) Updates FY18 Earnings GuidanceBecton Dickinson and (BDX) Updates FY18 Earnings Guidance
www.americanbankingnews.com - February 6 at 10:02 AM
Becton Dickinson and (BDX) Releases Quarterly  Earnings Results, Beats Expectations By $0.07 EPSBecton Dickinson and (BDX) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS
www.americanbankingnews.com - February 6 at 10:02 AM
Becton Dickinson (BDX) Tops Q1 EPS by 7cBecton Dickinson (BDX) Tops Q1 EPS by 7c
www.streetinsider.com - February 6 at 9:49 AM
Becton, Dickinson adjusted profit beats viewsBecton, Dickinson adjusted profit beats views
www.marketwatch.com - February 6 at 9:49 AM
Becton, Dickinson (BDX) Beats on Q1 Earnings, Guidance SolidBecton, Dickinson (BDX) Beats on Q1 Earnings, Guidance Solid
www.zacks.com - February 6 at 9:49 AM
BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of BardBD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard
finance.yahoo.com - February 6 at 9:49 AM
Becton Dickinson reports 1Q lossBecton Dickinson reports 1Q loss
finance.yahoo.com - February 6 at 9:49 AM
Becton (BDX) Beats on Q1 Earnings and Revenues EstimatesBecton (BDX) Beats on Q1 Earnings and Revenues Estimates
finance.yahoo.com - February 6 at 9:49 AM
Medical Product Stocks' Earnings on Feb 6: BDX, LH & MoreMedical Product Stocks' Earnings on Feb 6: BDX, LH & More
finance.yahoo.com - February 5 at 3:43 PM
Comparable Historical Revenue Schedules Inclusive of C. R. Bard Posted to BD WebsiteComparable Historical Revenue Schedules Inclusive of C. R. Bard Posted to BD Website
www.prnewswire.com - February 2 at 10:33 PM
 Brokerages Expect Becton Dickinson and Co (BDX) Will Post Quarterly Sales of $3.05 Billion Brokerages Expect Becton Dickinson and Co (BDX) Will Post Quarterly Sales of $3.05 Billion
www.americanbankingnews.com - February 2 at 1:25 PM
Should You Buy Becton, Dickinson (BDX) Ahead of Earnings?Should You Buy Becton, Dickinson (BDX) Ahead of Earnings?
finance.yahoo.com - February 2 at 9:43 AM
BD Launches New Los Angeles County Program to Equip Patients with Essential Resources for Safe Sharps DisposalBD Launches New Los Angeles County Program to Equip Patients with Essential Resources for Safe Sharps Disposal
finance.yahoo.com - February 1 at 9:58 AM
$2.40 EPS Expected for Becton Dickinson and Co (BDX) This Quarter$2.40 EPS Expected for Becton Dickinson and Co (BDX) This Quarter
www.americanbankingnews.com - January 31 at 3:16 AM
Becton Dickinson and Co (BDX) Sees Significant Decrease in Short InterestBecton Dickinson and Co (BDX) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - January 30 at 2:40 AM
BDX Crosses Above Average Analyst TargetBDX Crosses Above Average Analyst Target
www.nasdaq.com - January 29 at 9:58 AM
Could Thermo Fisher Scientific See Earnings Growth in 4Q17?Could Thermo Fisher Scientific See Earnings Growth in 4Q17?
finance.yahoo.com - January 26 at 9:31 AM
Whats in Store for Becton, Dickinson (BDX) in Q1 Earnings?What's in Store for Becton, Dickinson (BDX) in Q1 Earnings?
finance.yahoo.com - January 25 at 9:52 AM
What's in Store for Becton, Dickinson (BDX) in Q1 Earnings?What's in Store for Becton, Dickinson (BDX) in Q1 Earnings?
finance.yahoo.com - January 25 at 9:52 AM
Daily Dividend Report: KMB, WEC, PETS, BDX, WPZ, WYNN - NasdaqDaily Dividend Report: KMB, WEC, PETS, BDX, WPZ, WYNN - Nasdaq
www.nasdaq.com - January 24 at 8:10 AM
Becton Dickinson and (BDX) to Release Earnings on WednesdayBecton Dickinson and (BDX) to Release Earnings on Wednesday
www.americanbankingnews.com - January 24 at 3:56 AM
BD Board Declares DividendBD Board Declares Dividend
finance.yahoo.com - January 23 at 5:23 PM
Becton Dickinson and Co (BDX) Declares $0.75 Quarterly DividendBecton Dickinson and Co (BDX) Declares $0.75 Quarterly Dividend
www.americanbankingnews.com - January 22 at 6:31 PM
Interesting BDX Put And Call Options For September 21stInteresting BDX Put And Call Options For September 21st
www.nasdaq.com - January 22 at 3:57 PM

SEC Filings

Becton Dickinson and (NYSE:BDX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Becton Dickinson and (NYSE:BDX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Becton Dickinson and (NYSE BDX) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.